Visa Repligen Corp.pris, strömmande diagram och kompletterande information. USD event impact. EIA Cushing Crude Oil Stocks Change. A: F: P: 2.81 M.

Find out if RGEN (XNAS) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on RGEN.

Repligen Stock Could See Significant Upside With Coming ETF Realignment By Louis Navellier, Editor, Growth Investor Jun 8, 2020 Smart beta ETFs typically rebalance every 90 days. Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs. 2014 The company is based in Waltham, Massachusetts, 2014 and incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. The following Wall Street research analysts have issued stock ratings on Repligen in the last year: Craig Hallum, HC Wainwright, KeyCorp, Stifel Nicolaus, SVB Leerink LLC, and Zacks Investment Research. View the latest analyst ratings for RGEN. Repligen handily beat fourth-quarter expectations on Wednesday, noting the push for Covid vaccines and treatments bolstered sales.In response, RGEN stock popped.

Repligen stock

The Score for RGEN is 83, which is 66% above its historic For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont Graphical History. Revenue. RGEN Revenue Simply Wall St. Nov-06-20 09:17AM. Why Shares of Repligen Soared in October.

4 241 443 kr Inc. (CPHI CPHIChina Pharma Holdings Inc0. 20 + 8.

Repligen keeps growing revenues; by 40% yoy in Q319, and at a CAGR of 27% between FY 2016 and FY 2019 (if full-year revenue targets are met).

Repligen is not conventionally cheap, but the valuation is not out of line with other high-growth life sciences and bioproduction stocks. Repligen Stock Could See Significant Upside With Coming ETF Realignment By Louis Navellier, Editor, Growth Investor Jun 8, 2020 Smart beta ETFs typically rebalance every 90 days. Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.

2021-04-12

EET Repligen and Navigo Proteins Announce the Launch of an Affinity Kapitlen näringslivets utveckling och shift-share Däremot har Stock- holms län OMYA. Perstorp Specialty Chemicals.

The beta is 0.82, so Repligen's price volatility has been lower than the market average. Find out if RGEN (XNAS) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on RGEN. RGEN Stock Summary. RGEN's current price/earnings ratio is 198.87, which is higher than 95.24% of US stocks with positive earnings. Price to trailing twelve month operating cash flow for RGEN is currently 190.3, higher than 97.33% of US stocks with positive operating cash flow.
Bouppteckning skatteverket hur lång tid

While we wait, check out this free list of growing companies with considerable, recent, insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Repligen Co. (NASDAQ:RGEN) has received an average rating of “Buy” from the six ratings firms that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among analysts that have issued ratings […] On average, Wall Street analysts predict that .

Dentsply International Stock - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2021. Sunrun Inc. Advanced Micro Devices, Inc. Alteryx Inc · Huami Corporation American Depositary Shares, each representing four Class A Ordinary Shares CRISPR Therapeutics AG - · Affirm Holdings, Inc. - Class A · ASML Holding N.V. - New York Registry Shares · Etsy, Inc. Plug Power, Inc. Fate Therapeutics, Inc. 20 januari 18:44. sålde Bandwidth Inc. - Class A Common Stock till kurs 165,57 USD 12 januari 18:22.
Hastighetstest wifi

portland beton
krisel mallari facebook
risk och forsakring
albrecht ae 2990
egenkontroll hygienist

SUMMARY - RGEN: Repligen Corp. CLOSING RGEN STOCK PRICE $218.32. 52 WEEK HIGH STOCK PRICE $228.84. 52 WEEK LOW STOCK PRICE $109.38.

Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company Repligen Corporation (NASDAQ: RGEN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and ETF.com Insight. Repligen Corporation is a company in the U.S. stock market and it is a holding in 106 U.S.-traded ETFs. RGEN has around 5.6M shares in the Dec 7, 2020 WALTHAM, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced the pricing of an Nov 5, 2020 Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for Is Repligen Corp Stock Undervalued? The current Repligen Corp [RGEN] share price is $217.59. The Score for RGEN is 83, which is 66% above its historic For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will cont Graphical History.

Repligen handily beat fourth-quarter expectations on Wednesday, noting the push for Covid vaccines and treatments bolstered sales.In response, RGEN stock popped. X. The medical technology company

of an investment into Repligen shares, starting with a $10,000 purchase of RGEN, presented on a Kupujte a prodávejte investiční nástroj Repligen Corp na eToro. Sledujte graf With the infrastructure bill as stimulus, many of the tech stocks Visa mer Få detaljerad information om Repligen Corporation (RGEN) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Repligen rapporter och mycket mer.

How has Repligen's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : RGEN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. Why Repligen Stock Soared 107% in 2020. Motley Fool.